Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology Annual Meeting
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer
Noble Announces Filing of NI 43-101 Technical Report for Previously Announced Mann Central and Mann West Initial Resources
SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation for Major Drill Program at the 100% Owned Radar Titanium Property in Labrador, Canada
Homerun Resources Inc. Appoints Strand Hanson Limited as UK Financial Adviser to Explore Dual Listing on London Stock Exchange
Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan
LaFleur Minerals Engages Advisors for Strategic Beacon Gold Mill Restart Debt Financing and Announces LIFE and Charity Flow-Through Unit Offerings
